课题基金 / 基金详情

Development of a hybrid technology for treating recalcitrant water contaminants: assessing e-beam potential.

Development of a hybrid technology for treating recalcitrant water contaminants: assessing e-beam potential.
开发处理顽固水污染物的混合技术:评估电子束潜力。
批准号:
ST/K006487/1
负责人:
Thomas Scott
金额:
$2.31万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

Thomas Scott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Manufacture is faced with the escalating challenges of resource limitation, conservation of water and the treatment of waste, whilst attempting to reduce its carbon foot-print. There is increasing realisation within industry that it is a long way from achieving the efficiency of natural systems where resources such as water, metals and organics are apparently effortlessly recycled or transformed to clean energy. This is challenging enough but it is even more daunting with the realisation that end-of-pipe industrial effluent from key manufacturing processes, such as metal working and plating, and landfill leachate are chemically mixed with high concentrations, are toxic and temporally fluctuate enormously in terms chemical composition. Until now such effluents have been considered to be significant environmental problems, costly to deal with and reliant on high capital and energy demanding technologies, such as reverse osmosis and ultra-filtration. However, with climate change and increasing pressure on natural resources industry's attitude has changed with the drive now on resource recovery and treatment on site, in order to reduce the carbon footprint associated with transportation. A growing concern is the increasing realisation that current wastewater technology procedures aimed at end-of-pipe recovery from recalcitrant effluent are all energy demanding and inefficient. This requires radical new thinking in an important but neglected area.The objective of this study is to develop new approaches and in particular test novel technological combinations (biocatalysis, zero valent nano-Fe [nZVI] and electron beam accelerators) for treating recalcitrant and chemically mixed industrial waste waters. The primary focus is to reduce the energy demand of the developed process and to harmonise the complementary technologies to sustainably degrade the organic component and precipitate, immobilise and enable metal recovery, whilst recovering the water. Chemically mixed wastewater and chlorine contaminated ground will be assessed for treatability by exploiting microbes able to biotransform such contaminants. This step will remove the readily degradable component of the effluent leaving the recalcitrant residues, that will be transferred to subsequent treatment exposures including addition of zero valent nano-Fe (nZVI). This is a highly reactive step, catalysing the chemical disintegration of recalcitrant residues, including large polymers and chemical complexes, so making them more conducive to a final biodegradation step. Biologically pre-treated recalcitrant effluent residues will also be treated by exposure to the e-beam, leading to radiolysis, production of H+ and OH radicals, resulting in vigorous reducing and oxidations conditions, and the organic becoming more bioavailable to microbiological treatment. The novel combination of nZVI with the e-beam, with a final biodegradation step, we believe will lead to the destruction of most recalcitrant residues. Parallel lab tests will be established to determine the effectiveness of all three treatments (microbiological, nZVI and e-beam) on the chemical state of the metals, immobilisation and recovery by precipitation.A broad range of waste waters will be investigated, both end-of-pipe industrial and contaminated ground-waters. A key issue will be the feasibility of converting developed technologies for transforming the organic component to useful products and recovery of the metals are feasible, scaleable and can with some development be commercialised.The primary focus of this study will be the e-beam component, in particular assessment of procedures for improving its efficiency, lowering its energy requirement since will be a key requirement in order to being commercially viable. We will also determine the most effective microbial cells at the end of the biodegradative component of the treatment.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cej.2015.03.085
发表时间: 2015-10-01
期刊: CHEMICAL ENGINEERING JOURNAL
影响因子: 15.1
作者: [Crane, Richard A., Pullin, Huw, Scott, Thomas B.]
通讯作者: Scott, Thomas B.
Hybrid biological, electron beam and zero-valent nano iron treatment of recalcitrant metalworking fluids.
顽固金属加工液的混合生物、电子束和零价纳米铁处理。
DOI: 10.1016/j.watres.2016.02.028
发表时间: 2016
期刊: Water research
影响因子: 12.8
作者: [Thill PG]
通讯作者: Thill PG
ChemInform Abstract: Nano-Composites for Water Remediation: A Review
ChemInform 摘要:用于水修复的纳米复合材料:综述
DOI: 10.1002/chin.201443227
发表时间: 2014
期刊: ChemInform
影响因子: --
作者: [Tesh S]
通讯作者: Tesh S
A novel voltaic for direct gamma-electric power generation
  • 批准号:
    ST/W005255/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $20.6万
  • 财政年份:
    2022
  • 负责人:
    Thomas Scott
  • 依托单位:
'OptiClean' - Optimised laser cleaning for safe nuclear decontamination and decommissioning
  • 批准号:
    EP/W016265/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $64.38万
  • 财政年份:
    2021
  • 负责人:
    Thomas Scott
  • 依托单位:
MicroNOVA - A novel compact particle generator for medical applications
  • 批准号:
    ST/W002221/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $100.78万
  • 财政年份:
    2021
  • 负责人:
    Thomas Scott
  • 依托单位:
net-zero - Tracking tritium to enable efficient fusion fuel cycles
  • 批准号:
    ST/W002418/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $20.57万
  • 财政年份:
    2021
  • 负责人:
    Thomas Scott
  • 依托单位:
国内基金
海外基金
一种经心房覆膜血管支架植入 Hybrid Fontan 手术的 临床新技术研究
基于深度压缩技术的Hybrid像素探测器读出系统原型机研制
  • 批准号:
    11875146
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2018
  • 负责人:
    王东
  • 依托单位:
模拟胰岛“hybrid”修饰抗原诱导tolDC免疫保护1型糖尿病β细胞研究
  • 批准号:
    81770777
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2017
  • 负责人:
    顾愹
  • 依托单位:
PSMA靶向Hybrid-SiO2基纳米诊疗剂用于前列腺癌HIFU治疗及增效机制研究
  • 批准号:
    81601499
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    姚明华
  • 依托单位: